Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Crystapen 1.2g powder for solution for injection vials
0501011J0BBAFAF
|
Crystapen | Benzylpenicillin sodium (Penicillin G) | Infections | No data available |
|
Crystapen 600mg powder for solution for injection vials
0501011J0BBABAB
|
Crystapen | Benzylpenicillin sodium (Penicillin G) | Infections | No data available |
|
Cubicin 350mg pdr for concentrate for inf vials
0501070Y0BBAAAA
|
Cubicin | Daptomycin | Infections | No data available |
|
Cubicin 500mg pdr for concentrate for inf vials
0501070Y0BBABAB
|
Cubicin | Daptomycin | Infections | No data available |
|
Cymevene 250mg capsules
0503022D0BBABAC
|
Cymevene | Ganciclovir | Infections | No data available |
|
Cymevene 500mg capsules
0503022D0BBACAD
|
Cymevene | Ganciclovir | Infections | No data available |
|
Cymevene 500mg pdr for concentrate for inf vials
0503022D0BBAAAA
|
Cymevene | Ganciclovir | Infections | No data available |
|
Cysticide 500mg tablets
0505050P0BEAAAB
|
Cysticide | Praziquantel | Infections | No data available |
|
Daclatasvir 30mg tablets
0503032E0AAABAB
|
Daclatasvir | Daclatasvir | Infections | No data available |
|
Daclatasvir 60mg tablets
0503032E0AAAAAA
|
Daclatasvir | Daclatasvir | Infections | No data available |
|
Daclatasvir 90mg tablets
0503032E0AAACAC
|
Daclatasvir | Daclatasvir | Infections | No data available |
|
Daklinza 30mg tablets
0503032E0BBABAB
|
Daklinza | Daclatasvir | Infections | No data available |
|
Daklinza 60mg tablets
0503032E0BBAAAA
|
Daklinza | Daclatasvir | Infections | No data available |
|
Daklinza 90mg tablets
0503032E0BBACAC
|
Daklinza | Daclatasvir | Infections | No data available |
|
Dalacin C Phosphate 300mg/2ml inj ampoules
0501060E0BBAAAA
|
Dalacin C Phosphate | Clindamycin phosphate | Infections | No data available |
|
Dalacin C Phosphate 600mg/4ml inj ampoules
0501060E0BBABAB
|
Dalacin C Phosphate | Clindamycin phosphate | Infections | No data available |
|
Dalbavancin 500mg powder for solution for infusion vials
0501070AFAAAAAA
|
Dalbavancin hydrochloride | Dalbavancin hydrochloride | Infections | No data available |
|
Dapsone 100mg / Pyrimethamine 12.5mg tablets
0504010Q0AAAAAA
|
Pyrimethamine/dapsone | Pyrimethamine with dapsone | Infections | No data available |
|
Dapsone 20mg/5ml oral suspension
0501100H0AAAPAP
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 40mg/5ml oral suspension
0501100H0AAAMAM
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 50mg/5ml oral suspension
0501100H0AAALAL
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 5mg/5ml oral liquid
0501100H0AAAKAK
|
Dapsone | Dapsone | Infections | No data available |
|
Dapsone 75mg/5ml oral suspension
0501100H0AAANAN
|
Dapsone | Dapsone | Infections | No data available |
|
Daptomycin 350mg powder for solution for infusion vials
0501070Y0AAAAAA
|
Daptomycin | Daptomycin | Infections | No data available |
|
Daptomycin 500mg powder for solution for infusion vials
0501070Y0AAABAB
|
Daptomycin | Daptomycin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.